Multivariate functional linear discriminant analysis with feature selection: an application to inflammatory bowel...

Area of Science:

• Microbiome Research
• Computational Biology
• Gastroenterology

Background:

• Inflammatory Bowel Disease (IBD), encompassing Crohn's Disease (CD) and Ulcerative Colitis (UC), poses significant public health challenges due to its intricate origins.
• Current microbiome research often employs limited analytical approaches, hindering a comprehensive understanding of temporal dynamics and complex interactions.
• The Integrative Human Microbiome Project provided a foundation for exploring microbial contributions to IBD.

Purpose of the Study:

• To identify specific microbial pathways that differentiate between CD, UC, and non-IBD individuals over time.
• To overcome the limitations of existing analytical methods in handling high-dimensional, time-series microbiome data with categorical outcomes.

Main Methods:

• Development of a novel functional data analysis approach for discriminant analysis of multivariate functional data.
• The method accommodates multiple high-dimensional predictors, sparse time points, and categorical outcomes.
• Incorporation of a sparsity-inducing penalty to identify key discriminating microbial variables over time.

Main Results:

• Identification of microbial features associated with mucin degradation, amino acid metabolism, and peptidoglycan recognition as significant in IBD development.
• Highlighting the potential role of multiple vitamin B deficiencies in the context of IBD.
• Demonstration of the method's capability to uncover dynamic microbial differences across IBD subtypes and healthy controls.

Conclusions:

• The novel functional data analysis approach offers a powerful tool for dissecting complex microbiome-host interactions in IBD.
• This method moves beyond traditional frameworks, enabling the discovery of clinically relevant microbial signatures and metabolic pathways.
• Findings suggest new avenues for understanding IBD pathogenesis and potential therapeutic targets, including addressing vitamin deficiencies.